Sign up


Match Document Document Title
8445035 Dietary supplements containing extracts of aronia and method of using same to promote weight loss  
A dietary supplement composition comprising aronia extract containing at least 20% anthocyanins by dry weight. The aronia extract is derived from the aronia melanocarpa plant. The aronia extract...
8445031 Method for producing purified tea extract  
A purified tea extract is improved in taste by reducing a percentage of gallates in the non-polymer catechins. A process according to the present invention for the production of a purified tea...
8444970 Compositions and methods for treating ocular diseases and conditions  
The present invention relates to compositions and methods for prevention and treatment of diseases and conditions, particularly ocular diseases and conditions, characterized by aberrant...
8445039 Antioxidant cosmetic composition containing extract of processed peony, polygonati rhizoma or lily  
The present invention relates to an antioxidant cosmetic composition, and more particularly to an antioxidant cosmetic composition containing, as an active ingredient, either an extract of at least...
8444999 Mutated Salmonella typhi strain and use thereof in a vaccine  
The present invention relates to an attenuated Salmonella typhi having mutation in chromosomal gene loci, its use as a potent vaccine candidate to combat the Salmonella infection.
8445444 Compositions and methods for diagnosing, treating, and preventing prostate conditions  
Disclosed are compositions and methods for diagnosing, preventing, and treating prostate cancer and prostate intraepithelial neoplasia (PIN).
8444977 Assay method for Alzheimer's disease  
A diagnostic test for preclinical and clinical Alzheimer's disease is based on plasma levels of Aβ40, Aβ42, their ratio, or their rate of entry following administration of antibodies that s...
8444969 Neutrophil-depleted platelet rich plasma formulations for cardiac treatments  
Compositions and methods for preparing neutrophil-depleted platelet rich plasma are provided. Generally, these compositions comprise a higher concentration of platelets and depressed concentrations...
8445028 Echinoderm-derived extracts, methods of preparation and uses thereof  
An Echinozoa tissue or organ extract comprising antioxidant compounds is disclosed. Also disclosed is a process for obtaining an Echinozoa tissue or organ extract, as well an extract obtained by...
8445030 Persistent and fast acting antiseptics and disinfectants based on calcium fluoride  
Antiseptic compounds that act as persistent and fast acting antiseptics and disinfectants. The base of these antiseptic actions is CaF2 as the persistent part, preventing the colonization of tissue...
8445275 Induction of dendritic cell development with macrophage-colony stimulating factor (M-CSF)  
A method of inducing dendritic cell (DC) development by administering Macrophage-Colony Stimulating Factor (M-CSF) is provided. M-CSF induces DCs to differentiate into Subtypes, for example...
8444975 Method for inhibiting bone resorption  
This invention relates, in part, to unique and newly identified genetic polynucleotides involved in the process of bone remodeling; variants and derivatives of the polynucleotides and corresponding...
8445725 Process for the preparation of iosimenol  
A process for the preparation of iosimenol comprising reacting 5,5′-[(1,3-dioxo-1,3-propanediyl)diimino]bis[N-(2,3-dihydr oxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide] (C-VI) with a 3...
8445006 Biomolecular coating for implants  
Methods and compositions are provided for improving tissue growth and device integration in vivo. Substrates and devices coated with an α2β1 or α5β1 integrin-specific ligand are provided. The sub...
8445021 Functionalized magnetic nanoparticles and methods of use thereof  
The present disclosure provides compositions comprising 2-deoxyglucose-functionalized magnetic nanoparticles. The compositions are useful in various applications, which are also provided.
8445032 Melt-blended protein composition  
A melt-processed protein composition formed from a protein, plasticizer, and an electrophilic reagent is provided. The electrophilic reagent, for instance, may be selected to undergo a nucleophilic...
8444957 Methods of screening for neoplastic disease states  
The present invention provide purified Flt4 receptor tyrosine kinase polypeptides and fragments thereof, polynucleotides encoding such polypeptides, antibodies that specifically bind such...
8445007 Bis-(α-amino)-diol-diester-containing poly (ester amide) and poly (ester urethane) compositions and methods of use  
The present invention provides biodegradable, biocompatible bis-(α-amino acyl)-diol-diester-containing poly(ester amide) (PEA) and poly(ester urethane) (PEUR) co-polymer compositions with ...
8444962 Bioremediation method for accelerated biological decomposition of petroleum hydrocarbons in sea ice-covered polar regions, and bacteria and enzyme mixtures as agents for carrying out said method  
A bioremediation method for accelerated biological degradation of petroleum hydrocarbons in a sea ice-covered polar region comprising contacting the petroleum hydrocarbons with an inoculum. The...
8444992 Multiple vaccination including serogroup C meningococcus  
Various improvements to vaccines that include a serogroup C meningococcal conjugate antigen, including: (a) co-administration with acellular B. pertussis antigen; (b) co-administration with an...
8444771 Method for cleaning and/or deodorizing toilet bowl or urinal using an adhesive agent  
Method for cleaning and/or deodorizing a toilet bowl or urinal. In one embodiment, the method involves directly applying an agent to the toilet bowl or urinal. The agent adheres to the toilet bowl...
8445041 Dehydrated castor oil as an animal feed supplement  
The present invention relates to a method for improving the fat firmness and meat quality of a meat animal and/or altering the ratio of saturated fatty acids to unsaturated fatty acids in meat by...
8445008 Reduction of infection associated with medical device  
Anti-infective articles capable of preventing infection associated with implantation of medical devices include low levels of anti-infective agents, may cover only a fraction of the portion of the...
8444987 Compositions and methods for the diagnosis and treatment of immune disorders  
The present invention relates to methods and compositions for the treatment and diagnosis of immune disorders, especially T helper lymphocyte-related disorders. In particular, the invention...
8445012 Compositions and methods for delivery of embolics  
Described herein are compositions comprising one or more embolics attached to an inert, dissolvable matrix as well as kits comprising these novel embolic formulations. Also described are methods of...
8445040 Extracts of Sclerocarya birrea  
Provided are extracts obtained from the marula fruit (Sclerocarya Birrea) and uses thereof in a great variety of applications, e.g., use in food supplements for engendering an anti-atherogenic...
8444973 Anti-CD19 antibodies and uses in B cell disorders  
The invention relates to immunotherapeutic compositions and methods for the treatment of B cell diseases and disorders in human subjects, such as, but not limited to, B cell malignancies and...
8445749 Bacillus thuringiensis gene with lepidopteran activity  
The invention provides nucleic acids, and variants and fragments thereof, obtained from strains of Bacillus thuringiensis encoding polypeptides having pesticidal activity against insect pests,...
8444996 Multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia  
Disclosed are immunogenic conjugates which elicit an immune response to Plasmodium proteins. In particular examples, the Plasmodium proteins include sexual stage surface proteins, circumsporozoite...
8444989 One dose vaccination against mycoplasma infections of pigs  
The present invention provides a one phase, aqueous vaccine composition for immunizing an animal against infection by Mycoplasma hyopneumoniae, comprising: an immunizing amount of a Mycoplasma...
8445650 Mutant botulinum neurotoxin serotype A polypeptide and uses thereof  
Modified polypeptides based on the botulinum neurotoxin A heavy chain containing the double mutation Trp-Tyr->Leu-Ser in the ganglioside binding motif Ser-X-Trp-Tyr do not bind...
8444980 Therapeutic use of anti-CS1 antibodies  
The present invention is directed to antagonists of CS1 that bind to and neutralize at least one biological activity of CS1. The invention also includes a pharmaceutical composition comprising such...
8445009 Processes for the production of solid dressings for treating wounded tissue  
Disclosed are processes for preparing solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of a fibrinogen...
8445724 Preparation of iodixanol  
A process for the manufacture of iodixanol by performing a purification process of the crude product in a solvent comprising 1-methoxy-2-propanol. The crude product may be obtained in aqueous...
8445426 Peptides and methods for producing them  
The present invention relates to the fields of life sciences and food, feed or pharmaceutical industry. Specifically, the invention relates to novel peptides, pilus structures, polynucleotides as...
8444959 Topical skin care formulations comprising plant extracts  
Disclosed is a topical skin composition and corresponding methods for its use that includes a first MMP-1 inhibitor, wherein said first inhibitor is an extract from Burretiodendron hsienmu, a...
8444972 Antitumor antibodies, proteins, and uses thereof  
Antibodies that bind to a 40 kDa protein which is expressed on tumors, but is not expressed on normal adult hemopoietic cells are disclosed. Also disclosed are methods for production and the use of...
8445011 Delayed-release formulation for reducing the frequency of urination and method of use thereof  
Methods and compositions for reducing the frequency of urination are disclosed. One method comprises administering to a subject in need thereof an effective amount of a pharmaceutical composition...
8445033 Formulation for prevention and treatment of bacterial infections and preparation thereof  
The invention provides a formulation for the prevention and treatment of bacterial infections by administering an effective amount of the formulation comprising an extract of at least one plant...
8444593 Method for testing peritoneum function and a peritoneal dialysis planning apparatus  
A peritoneal function testing method uses a ratio of MTACun/MTACc, calculated using MTACun and MTACc, as an index for a peritoneal function test, wherein MTACun is an overall mass transfer-area...
8445019 Microparticle dispersion liquid manufacturing method and microparticle dispersion liquid manufacturing apparatus  
In a dissolving step, a poorly soluble drug and a dispersion stabilizer are dissolved in a volatile organic solvent. In a fixing step, the organic solvent, contained in a solution obtained in the...
8444995 Peptide sequences and compositions  
Provided is a polypeptide having no more than 100 amino acids, which polypeptide comprises one or more sequences having at least 60% homology with any of SEQ ID 1-6, or comprises two or more...
8445022 Embolization  
Embolization, as well as related particles, compositions, and methods, are disclosed.
8444960 Topical administration carrier composition and therapeutic formulations comprising same  
A topical administration carrier composition including water, glycerin and polysorbate, suitable for use in formulations with active ingredient compositions containing active ingredients such as...
8445284 Fixative and staining solutions  
The formulations, systems, and methods disclosed herein permit automated preparation of specimens (e.g., biological specimens) for examination. The formulations can include a cytological fixative...
8444978 Angiogenic and immunologic applications of anti-CD160 specific compounds obtainable from mAb CL1-R2  
The present invention relates to biological and medical applications of an anti-CD160 monoclonal antibody (CL1-R2 CNCM I-3204) and of the conservative equivalents thereof. It more particularly...
8444954 Gastrin releasing peptide compounds  
New and improved compounds for use in diagnostic imaging or therapy having the formula M-N—O—P-G, wherein M is a metal chelator having the structure: wherein R1-R5 and FG are as defined herein (in...
8445648 Methods and products relating to GSK3β regulation  
The invention relates to methods and compositions for regulation of GSK3β activity. The invention provides phosphorylated GSK3β polypeptides and antibodies that recognize such polypeptides. The i...
8444985 Vaccine compositions and methods for treatment of mucormycosis and other fungal diseases  
The present invention provides therapeutic compositions and methods for treating and preventing fungal disease or conditions including mucormycosis. The therapeutic methods and compositions of the...
8444967 Treatment including prebiotic composition for use with probiotics  
A method is described to treat diarrhea, vaginal yeast infections, constipation, heartburn, bloating, indigestion, flatulence or poor nutrient absorption, by administering a formulation of...